Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Suh

Showing results (981-990 of 1,004) with videos related to

Pageof 101
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classesJ H Chung, E Sanford, A Johnson, et al.
The Oncologist|March 13, 2020
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704Marsha Reyngold, Kathryn A Winter, William F Regine, et al.
Annals of Internal Medicine|February 18, 2020
Adverse Effects of Low-Dose Methotrexate: A Randomized TrialDaniel H Solomon, Robert J Glynn, Elizabeth W Karlson, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
Science Translational Medicine|June 5, 2024
Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degenerationMarvin Reich, Matthew J Simon, Beate Polke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk MeningiomaRupesh Kotecha, Mei-Yin Polley, Michael A Vogelbaum, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal DementiaJennifer Hsiao-Nakamoto, Chi-Lu Chiu, Lawren VandeVrede, et al.
Actas Dermo-Sifiliograficas|April 23, 2018
The First Year of the AEVD Primary Cutaneous Lymphoma RegistryY Peñate, O Servitje, S Machan, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
The Lancet. Oncology|June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Pageof 101

Showing results (981-990 of 1,004) with videos related to

Sort By:
Pageof 101
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classesJ H Chung, E Sanford, A Johnson, et al.
The Oncologist|March 13, 2020
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704Marsha Reyngold, Kathryn A Winter, William F Regine, et al.
Annals of Internal Medicine|February 18, 2020
Adverse Effects of Low-Dose Methotrexate: A Randomized TrialDaniel H Solomon, Robert J Glynn, Elizabeth W Karlson, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
Science Translational Medicine|June 5, 2024
Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degenerationMarvin Reich, Matthew J Simon, Beate Polke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk MeningiomaRupesh Kotecha, Mei-Yin Polley, Michael A Vogelbaum, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal DementiaJennifer Hsiao-Nakamoto, Chi-Lu Chiu, Lawren VandeVrede, et al.
Actas Dermo-Sifiliograficas|April 23, 2018
The First Year of the AEVD Primary Cutaneous Lymphoma RegistryY Peñate, O Servitje, S Machan, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
The Lancet. Oncology|June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Pageof 101